E. Ohman J:or Asset Management’s Amedisys AMED Stock Holding History

E. Ohman J:or Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,500	Closed	-$1.26M	–	410
2023 Q3	$1.26M	Sell	13,500 -2,600	-16%	-$240K	0.05%	205
2023 Q2	$1.47M	Buy	+16,100	New	+$1.32M	0.05%	199
2018 Q4	–	Sell	-120,639	Closed	-$15.1M	–	374
2018 Q3	$15.1M	Sell	120,639 -55,589	-32%	-$6.14M	0.97%	26
2018 Q2	$15.1M	Sell	176,228 -20,073	-10%	-$1.47M	1.07%	24
2018 Q1	$11.8M	Buy	196,301 +30,785	+19%	+$1.75M	0.95%	28
2017 Q4	$8.72M	Buy	+165,516	New	+$8.72M	0.71%	35

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

E. Ohman J:or Asset Management's AMED Position: Q4 2023 in Review

E. Ohman J:or Asset Management sold out of Amedisys (AMED) in Q4 2023, closing a stake of 13,500 shares — an estimated $1.26M sold.

E. Ohman J:or Asset Management first reported a position in AMED in Q4 2017 and held it in 6 quarters. The position peaked at $15.1M in Q3 2018. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

E. Ohman J:or Asset Management reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
E. Ohman J:or Asset Management sold 13,500 Amedisys shares in Q4 2023, an estimated $1.26M.
E. Ohman J:or Asset Management first reported a position in Amedisys in Q4 2017 and held it in 6 quarters.
E. Ohman J:or Asset Management's Amedisys position peaked at $15.1M in Q3 2018.
287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.